Sepsis Diagnostics Market Share, Size & Global Report 2024-2032
Sepsis Diagnostics Market Share, Size, Analysis Report, 2024-2032

Sepsis Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Blood Culture Media, Assay Kits & Reagents, Software); By Technology; By Pathogen; By Testing Type; By Region; Segment Forecast, 2024 - 2032

  • Published Date:Dec-2023
  • Pages: 116
  • Format: PDF
  • Report ID: PM1279
  • Base Year: 2023
  • Historical Data: 2019-2022

Report Outlook

The global sepsis Diagnostics market was valued at USD 682.30 million in 2023 and is expected to grow at a CAGR of 9.3% during the forecast period.

Sepsis is a potentially dangerous condition in which the body's response to an infection causes damage to its tissues. When the body's defense mechanisms inadvertently target its organs, normal functioning is disrupted, potentially leading to septic shock. Sepsis Diagnostics requires confirmation of the infection via indicators such as changes in mental status, systolic blood pressure, and respiratory rate.

Sepsis Diagnostics Market Size

To Understand More About this Research: Request a Free Sample Report

Several factors are driving the growth of the sepsis diagnostics market. Various factors, such as the widespread occurrence of sepsis, increased awareness of the condition, and the introduction of advanced diagnostic solutions. Sepsis is a serious medical threat caused by an intense immune response to infection. According to recent research, the global prevalence of this potentially fatal disease is increasing.

  • For instance, according to a publication by Springer Nature Switzerland AG in October 2021, the advancement of programs and guidelines plays a critical role in enhancing compliance with these bundles, thereby contributing to a reduction in mortality among patients with these specific conditions.

The research study provides a comprehensive analysis of the industry, assessing the market on the basis of various segments and sub-segments. It sheds light on the competitive landscape and introduces Sepsis Diagnostics Market key players from the perspective of market share, concentration ratio, etc. The study is a vital resource for understanding the growth drivers, opportunities, and challenges in the industry.

The rising prevalence of this disease poses a dual challenge to the economy and healthcare systems, particularly in developing countries. Various governmental and non-governmental organizations are actively engaged in efforts to raise public awareness about this illness. These initiatives typically include screening, educational campaigns, assessing the effectiveness of sepsis bundles, improved patient outcomes facilitated by advanced diagnostic methods, and the implementation of a treatment protocol.

Covid 19 has a significant impact on the sepsis diagnostics market. There has been a substantial increase in cases due to the increased prevalence of it among people with COVID-19. This trend was highlighted in a study published in the journal Frontiers in Medicine in the October 2021 issue. The International HOPE-COVID-19-Registry identified 624 cases of this condition in its analysis of 5,837 COVID-19 patients. Furthermore, the ongoing COVID-19 pandemic has had a positive impact on global sales of related products. Key market participants have reported significant revenue increases for fiscal year 2020. T2 Biosystems, Inc., for example, witnessed a remarkable 119.2% increase in annual revenues in 2020, and the company continued to experience consistent revenue growth throughout 2021.

During the lockdown, hospital visits and admissions for non-COVID-19 conditions decreased. Patients' unwillingness to visit hospitals due to perceived risks was a notable factor in this decrease. In order to manage the surge in COVID-19 admissions, some healthcare facilities temporarily stopped outpatient visits and non-urgent elective surgeries. As a result, the overall number of patient visits for non-COVID-19 reasons decreased throughout the pandemic.

Despite the availability of advanced medical care and broad-spectrum antibiotics, sepsis remains a significant contributor to both mortality and morbidity. Biomarkers are useful tools for enabling timely Diagnostics, identifying patient groups at high risk of complications, and monitoring disease progression. These evaluations are critical in designing effective therapies and improving patient outcomes.

Industry Dynamics

Growth Drivers

  • Increasing incidences of sepsis will drive the growth of the market

The rising incidences of sepsis will drive the growth of the market. Any infection has the potential to set off a chain of events that leads to organ failure and tissue damage, eventually leading to this disease. In 2021, the National Institute of General Medical Sciences reported that approximately 1.7 million adults had sepsis, with nearly 270,000 deaths in the United States. Because of the increasing frequency of these cases, there is a greater need for effective diagnostic measures.

Furthermore, people who are in the hospital or have recently been discharged are at a higher risk of infection, can contribute to the onset of this disease. According to data released by the Centers for Disease Control and Prevention (CDC) in August 2022, approximately one in every three people who died in a hospital setting had this condition during their hospital stay. The rising prevalence of the disease among hospitalized patients has increased the demand for diagnostic procedures, propelling the global market ahead during the forecast period.

Report Segmentation

The market is primarily segmented based on product, technology, pathogen, testing type and region.

By Product

By Technology

By Pathogen

By Testing Type

By Region

  • Instruments
  • Blood Culture Media
  • Assay Kits & Reagents
  • Software


  • Microbiology
  • Molecular Diagnostics
  • Biomarkers
  • Immunoassays
  • Flow Cytometry


  • Bacterial Sepsis
  • Gram Positive Bacteria
  • Gram Negative Bacteria
  • Fungal Sepsis
  • Others


  • Laboratory Testing
  • PoC Testing


  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

To Understand the Scope of this Report: Speak to Analyst

By Product Analysis

  • The blood culture media segment accounted for the largest revenue share

In 2023, the blood culture media segment held the largest revenue share. The segment is anticipated to maintain its dominance in the forecast period because clinicians regard blood culture as the most convenient and cost-effective testing method. The global market is divided into three product categories: instruments, blood culture media, and assay kits & reagents.

Blood cultures are considered by doctors to be the most practical and cost-effective testing method. This is especially important given the aging population, an increase in sepsis cases, an increase in bloodstream infections, a growing need for rapid diagnostic methods, and the occurrence of infectious diseases.

By Testing Type Analysis

  • The laboratory testing segment accounted for the highest market share during the forecast period

The laboratory testing segment held the highest market share during the forecast period. The primary reason for this is that lab testing is more accurate in diagnosing sepsis than point-of-care (POC) testing. Clinical laboratory testing provides a thorough examination of the pathogen and its drug resistance profile. Furthermore, despite the fact that lactate levels, which serve as a valuable marker for sepsis, are nonspecific, routine testing is carried out efficiently in laboratory settings.

The increasing availability of technologically advanced products has increased the general public's and medical professionals' reliance on laboratories. Laboratory testing is anticipated to increase at the fastest rate during the forecast period. This is owing to the rapid and highly accurate diagnostic capabilities it provides. Furthermore, the proliferation of diagnostic laboratories is expected to drive the growth of this segment in the forecast period.

Regional Insights

  • North America accounted for the largest market share in 2023

In 2023, North America held the largest market share in the sepsis diagnostics market. During the forecasted period, the area is expected to remain at the forefront. This growth is attributed to the presence of a strong healthcare infrastructure, which fosters increased acceptance of cutting-edge diagnostic solutions. Furthermore, the region benefits from the presence of key industry players as well as a favorable reimbursement framework, which contributes to the market's overall growth. Furthermore, the region's increased prevalence of sepsis and infectious diseases is anticipated to drive demand for innovative diagnostic solutions.

Asia Pacific is accounted for the fastest growth in the sepsis Diagnostics market. The increased number of new product approvals and launches has spurred the market in this region. Healthcare costs in Asia Pacific, excluding Japan (APEJ), are rising as the region's population grows and living standards improve. This has created significant opportunities for the rising septic diagnostic services market in this region.

Key Market Players & Competitive Insights

The market is characterized by intense competition, with established players relying on advanced technology, high-quality products, and a strong brand image to drive revenue growth. These companies employ various strategies such as research and development, mergers and acquisitions, and technological innovations to expand their product portfolios and maintain a competitive edge in the market.

Some of the major players operating in the global market include:

  • Abbott Laboratories
  • Axis-Shield Diagnostics
  • Becton Dickinson
  • Bruker
  • CytoSorbents
  • Danaher Corporation
  • EKF Diagnostics
  • Immunexpress
  • IoMérieux
  • Luminex
  • Response Biomedical
  • Roche Diagnostics
  • T2 Biosystems
  • Thermo Fisher Scientific

Recent Developments

  • In May 2023, BioFire Diagnostics launched the FilmArray BCID2 Panel, an advanced sepsis diagnostic assay capable of identifying more than 40 bacterial and fungal pathogens.
  • In April 2023, GenMark Diagnostics has launched the ePlex Blood Culture ID Panel, a diagnostic test capable of identifying more than 40 bacterial and fungal pathogens commonly linked to sepsis.
  • In March 2023, Sysmex Corporation has partnered with Nephron Pharmaceuticals aimed at creating a swift point-of-care diagnostic test for sepsis.

Sepsis Diagnostics Market Report Scope

Report Attributes


Market size value in 2024

USD 744.18 million

Revenue forecast in 2032

USD 1,520.23 million


9.3% from 2024 – 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD million and CAGR from 2024 to 2032

Segments Covered

By Product, By Technology, By Pathogen, By Testing Type, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa


Report customization as per your requirements with respect to countries, region and segmentation

In today’s hyper-connected world, running a business around the clock is no longer an option. And at Polaris Market Research, we get that. Our sales & analyst team is available 24x5 to assist you. Get all your queries and questions answered about the Sepsis Diagnostics Market report with a phone call or email, as and when needed.

Browse Our Top Selling Reports

Cocoa Derivatives Market Size, Share 2024 Research Report

Abaca Pulp Market Size, Share 2024 Research Report

Healthcare Finance Solutions Market Size, Share 2024 Research Report

Hirsutism Market Size, Share 2024 Research Report

Bring Your Own Device Market Size, Share 2024 Research Report


The global sepsis diagnostics market size is expected to reach USD 1,520.23 million by 2032

Key players in the market are Abbott Laboratories, Axis-Shield Diagnostics, Becton Dickinson, Bruker, CytoSorbents, Danaher Corporation

North America contribute notably towards the global sepsis diagnostics market

The global sepsis Diagnostics market is expected to grow at a CAGR of 9.3% during the forecast period.

The sepsis diagnostics market report covering key segments are product, technology, pathogen, testing type and region.